|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|
|||||||||||||||||||||||||||||
|
Connecting Science, Medicine, and IndustryKinexum serves the pharmaceutical, biotechnology, and other health products and services industries. We provide sophisticated and highly informed guidance for health product discovery, development and clinical integration including regulatory, funding, reimbursement, and marketing strategies. Our organizational values reflect our belief that it is not just what we do, but how we do it, that is important. Kinexum's interests and capabilities span pharmaceuticals, biologics, medical devices, diagnostics, and software systems. Kinexum applies first hand experience and expertise to create solutions for complex challenges. We provide broad capabilities and experience to catalyze strategic thinking, productivity, and transformation. Our services and capabilities span the product life cycle:
We assist health product innovators and companies with strategy and transition planning to effectively manage through the phases of healthcare product development. From early product design and development to the launch stage, Kinexum supports the needs for health product development. Kinexum CEO Discusses Challenges of Diabetes Product Development and the FDA - Part of the Problem or Part of the Solution to the Diabetes Epidemic: Dr. Alexander Fleming Joins Kelly Close on CNBC Broadcast to Discuss the Issues September 16, 2011 dLife examines how potential drugs and medical devices are reviewed by the FDA September 16, 2011 Seoul, South Korea Kinexum and RHI (Regulatory Harmonization Institute) collaborate with KHIDI (Korea Health Industry Development Institute) August 22, 2011 Copyright © 2004 Kinexum LLC | terms of use | privacy |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||